Friends! In this video, I'm going to do an analysis on Fiserv Stock and Intuitive surgical

AI-generated source summary

The current market analysis focuses on two stocks: FISV and ISRG. FISV is currently trading at $129.56, down 41.56% year-to-date and showing weakness. While its valuation metrics like P/E ratio and price to free cash flow are low (11.8x and 16.6x respectively), the significant debt load and declining EPS growth might be concerns. The stock has a bearish trend, but a potential bullish reversal is noted if it can break past $150. ISRG, trading at $441.12, has also seen a downturn, down 15.82% year-to-date. Despite a strong long-term growth trend and substantial revenue from recurring services, its recent EPS growth has slowed. The company's extensive installed base of Da Vinci robots and a strong recurring revenue model suggest resilience, but competition from Chinese manufacturers offering cheaper alternatives at 50% lower costs is a factor. A target of $470 is set for ISRG, with a failure bound at $438.50.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   27 Sept 2025, 20:18 UTC

   The analyst published the original source item.

2. First prediction resolved

   29 Sept 2025, 15:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   29 Sept 2025, 15:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:12 UTC

   Tahlil Plus began monitoring the extracted predictions.